表紙
市場調査レポート

狭心症の予測:主要8市場

Angina Pectoris Forecast in 8 Major Markets 2015-2025

発行 Black Swan Analysis 商品コード 339841
出版日 ページ情報 英文 50 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
狭心症の予測:主要8市場 Angina Pectoris Forecast in 8 Major Markets 2015-2025
出版日: 2015年09月01日 ページ情報: 英文 50 Pages
概要

狭心症は、心筋が酸素を豊富に含む血液を十分に供給できない時に (虚血) 痛みや不快感を感じます。狭心症の主因として、冠動脈疾患 (CAD) が挙げられます。

当レポートでは、主要8市場 (米国、フランス、ドイツ、イタリア、スペイン、英国、ブラジル、日本) における狭心症の現在の患者数 (性別、年齢コホート別) について調査分析し、現在の有病率のほか、疾患の概要、危険因子、疾患の診断と予後、主な症状や合併症など、体系的な情報を提供しています。

図表

イントロダクション

病因

危険因子と予防

疾患の診断

変異:地域/民族別

疾患予後と臨床経過

疾患に関連する主な合併症/特徴

患者数を定量化する手法

狭心症の有病率トップライン

狭心症患者の特徴

  • 狭心症の進行の経過
  • 狭心症患者のCADの程度
  • 狭心症患者とBMI
  • 狭心症患者のCACS
  • 重大なCADを認める狭心症患者の罹患血管
  • 狭心症の罹患血管の程度

狭心症に関連する合併症

略語

関連出版

患者ベースのオンラインデータベース

患者ベースの製品

価格のオンラインデータ・プラットフォーム

参考文献

付録

目次
Product Code: ANGP0010915

Angina Pectoris is the term given to the pain or discomfort felt when the heart muscle lacks an adequate supply of oxygen rich blood (ischaemia). The main cause of angina is coronary arterial disease (CAD), which is the obstruction of coronary arteries due to build up of atherosclerotic plaque. Other forms of angina include microvascular angina (MVD) also known as Cardiac Syndrome X. This report provides the current prevalent population for Angina Pectoris across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of course of progression, coronary vessels affected and associated co-morbidities of Angina Pectoris. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Angina Pectoris have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Angina Pectoris include:

  • Diabetes
  • Hypertension
  • Dyslipidemia
  • Chronic heart failure
  • Peripheral artery disease
  • Erectile dysfunction
  • Aortic valve sclerosis

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Angina Pectoris's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Angina Pectoris and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Angina Pectoris's prevalent population.
  • Identify sub-populations within Angina Pectoris which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Angina Pectoris patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions /Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for Angina Pectoris

Features of Angina Patients

  • Course of Progression of Angina
  • Degree of Coronary Artery Disease in Angina Patients
  • Angina Patients and BMI
  • CACS in Angina Patients
  • Vessels Affected in Angina Patients with Significant CAD
  • Angina Grades of Affected Vessel(s)

Associates Co-morbid Conditions of Angina

Abbreviations and Acronyms used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Figures

  • Canadian Cardiovascular Society (CCS) classification of Angina

List of Tables

  • Prevalence of Angina, total (000s)
  • Prevalence of Angina, males (000s)
  • Prevalence of Angina, females (000s)
  • The course of Angina in Angina patients, total (000s)
  • Type of chest pain observed in Angina patients, total (000s)
  • Angina patients by degree of CAD involvement, total (000s)
  • BMI status of Angina patients, total (000s)
  • CACS in Angina patients, total (000s)
  • Number of vessels affected by CAD in Angina patients, total (000s)
  • Location of the vessel affected by CAD in Angina patients, total (000s)
  • CCS Angina grade of single vessel CAD Angina patients, total (000s)
  • CCS Angina grade of double vessel CAD Angina patients, total (000s)
  • CCS Angina grade of triple vessel CAD Angina patients, total (000s)
  • Prevalence of Diabetes in Angina patients, total (000s)
  • Diabetes by degree of CAD involvement in Angina patients, total (000s)
  • Prevalence of Hypertension in Angina patients, total (000s)
  • Hypertension by degree of CAD involvement in Angina patients, total (000s)
  • Prevalence of PAD in Angina patients, total (000s)
  • CCS Angina Grade of PAD in Angina patients, total (000s)
  • Erectile dysfunction in Angina patients, males (000s)
  • Angina patients with a history of stroke by CCS class, total (000s)
  • Chronic Heart failure (CHF) in Angina patients by CCS class, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
  • USA Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
  • France Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
  • France Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
  • Germany Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
  • Germany Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
  • Italy Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
  • Italy Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
  • Spain Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
  • Spain Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
  • Japan Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
  • Japan Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
Back to Top